Literature DB >> 22891715

Echocardiographic abnormalities and associated factors in a cohort of asymptomatic HIV-infected patients.

Guillermo Isasti1, Isabel Pérez, Tamara Moreno, Fernando Cabrera, Rosario Palacios, Jesús Santos.   

Abstract

HIV patients have been reported to have a greater prevalence of echocardiographic abnormalities. We aimed to determine the prevalence of these abnormalities and their associated factors. This was an observational study of a cohort of asymptomatic HIV patients. Data were recorded on factors of cardiovascular interest and those related to HIV infection. All the subjects underwent a transthoracic echocardiogram. The study included 196 patients, 85.2% men, mean age 46.4 years, with a mean duration of HIV infection of 123.8 months and 27.6% with AIDS. Of the patients, 94.4% were on antiretroviral therapy and 92.5% of these had an undetectable viral load. The mean CD4 cell count was 544/mm(3). The following echocardiographic abnormalities were found: left ventricular (LV) hypertrophy 28.6%, LV diastolic dysfunction 19.9%, left atrial (LA) dilatation 7.7%, right ventricular (RV) systolic dysfunction 6.1%, pulmonary hypertension 2.6%, RV dilatation 2%, and (LV) systolic dysfunction 1%. LV hypertrophy was associated with diabetes mellitus (OR 5.3, 95% CI 1.8-15.3; p=0.001), LV diastolic dysfunction with age (OR for each extra 5 years 4.4, 95% CI 4.2-4.6; p=0.0001), obesity (OR 4.07, 95% CI 1.6-10.0; p=0.02), alcohol consumption (OR 2.5, 95% CI 1.07-6.2; p=0.03) and lower CD4 cell count (OR for each 10 CD4 cells less 10.02, 95% CI 10.00-10.04; p=0.008), and RV systolic dysfunction with hypertension (OR 5.4, 95% CI 1.6-18.2; p=0.005). Echocardiographic abnormalities in HIV patients were common, especially LV hypertrophy and diastolic dysfunction. Prospective comparative studies involving the general population are needed to determine the prevalence of HIV infection and its treatment in these abnormalities.

Entities:  

Mesh:

Year:  2012        PMID: 22891715     DOI: 10.1089/AID.2012.0096

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

Review 1.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

2.  Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients.

Authors:  Apostolos Karavidas; George Xylomenos; Vassiliki Matzaraki; Nikolaos Papoutsidakis; Georgios Leventopoulos; Dimitrios Farmakis; George Lazaros; Anastasia Perpinia; Sophia Arapi; Nikolaos Paisios; John Parissis; Vlasios Pyrgakis; Panagiotis Gargalianos
Journal:  Clin Res Cardiol       Date:  2015-05-15       Impact factor: 5.460

3.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.

Authors:  Courtney V Fletcher; Kathryn Staskus; Stephen W Wietgrefe; Meghan Rothenberger; Cavan Reilly; Jeffrey G Chipman; Greg J Beilman; Alexander Khoruts; Ann Thorkelson; Thomas E Schmidt; Jodi Anderson; Katherine Perkey; Mario Stevenson; Alan S Perelson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 4.  Human immunodeficiency virus and pulmonary arterial hypertension.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Aram Barbaryan; Suartcha Prueksaritanond
Journal:  ISRN Cardiol       Date:  2013-08-21

5.  Metabolic health across the BMI spectrum in HIV-infected and HIV-uninfected men.

Authors:  Jordan E Lake; Xiuhong Li; Frank J Palella; Kristine M Erlandson; Dorothy Wiley; Lawrence Kingsley; Lisa P Jacobson; Todd T Brown
Journal:  AIDS       Date:  2018-01-02       Impact factor: 4.632

6.  Hyperactive TGF-β Signaling in Smooth Muscle Cells Exposed to HIV-protein(s) and Cocaine: Role in Pulmonary Vasculopathy.

Authors:  Pranjali Dalvi; Himanshu Sharma; Tomara Konstantinova; Miles Sanderson; Amy O' Brien-Ladner; Navneet K Dhillon
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

7.  Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons.

Authors:  Kara W Chew; Chia-Ying Liu; Bharath Ambale-Venkatesh; Diana Liao; Tamara B Horwich; João A C Lima; David A Bluemke; J Paul Finn; Adeel A Butt; Judith S Currier
Journal:  J Int Med Res       Date:  2017-06-12       Impact factor: 1.671

8.  Pulmonary hypertension in the global population of adolescents and adults living with HIV: a systematic review and meta-analysis.

Authors:  Jean Joel Bigna; Jobert Richie Nansseu; Jean Jacques Noubiap
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

9.  Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa.

Authors:  Geert V T Roozen; Ruchika Meel; Joyce Peper; William D F Venter; Roos E Barth; Diederick E Grobbee; Kerstin Klipstein-Grobusch; Alinda G Vos
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

10.  Network of MicroRNAs Mediate Translational Repression of Bone Morphogenetic Protein Receptor-2: Involvement in HIV-Associated Pulmonary Vascular Remodeling.

Authors:  Mahendran Chinnappan; Aradhana Mohan; Stuti Agarwal; Pranjali Dalvi; Navneet K Dhillon
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.